News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



CORRECTED-Stem cell-derived pancreatic cells may be alternative to islet transplants

(In second sentence of paragraph 7, changes first word from "Three" to "Six": Six (35.3%) showed positive...) By Marilynn Larkin NEW YORK (Reuters Health) - An ongoing first-in-human trial suggests

Radiomic signature may predict survival in pembrolizumab-treated advanced melanoma

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with advanced melanoma treated with pembrolizumab monotherapy, a radiomic signature derived from baseline computed tomography (CT) images may

Drugmaker Teva fueled opioid addiction in New York, jury finds

By Brendan Pierson NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other

COVID is less severe with Omicron than Delta, U.S. study suggests

By Manojna Maddipatla and Leroy Leo (Reuters) - The Omicron variant appears to result in less severe COVID-19 than seen during previous periods of high coronavirus transmission including the Delta

No benefit to adding radiation to PD-L1/CTLA-4 therapy in resistant metastatic NSCLC

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with resistant metastatic non-small-cell lung cancer (NSCLC), adding radiation to PD-L1 and CTLA-4 inhibition alone or combination did not

Menstrual blood sequencing effective for HPV screening

By Reuters Staff (Reuters Health) - Screening for human papillomavirus (HPV) in high-risk individuals may be done effectively and noninvasively using menstrual blood testing with target-capture

EXCLUSIVE-U.S. funding to WHO fell by 25% during pandemic -document

By Francesco Guarascio and Emma Farge BRUSSELS/GENEVA (Reuters) - U.S. financial contributions to the World Health Organization (WHO) has fallen by 25% during the coronavirus pandemic, provisional

Fauci says 'prudent' to have Omicron vaccine, but may not be needed

By Reuters Staff WASHINGTON (Reuters) - A COVID-19 vaccine specifically targeting the Omicron variant would be "prudent" even if it ultimately may not be needed, the top U.S. infectious disease

Women with IBD expect their gastroenterologist to initiate discussion of reproductive health

By Matthew Phelan NEW YORK (Reuters Health) - Women with inflammatory bowel disease (IBD) often worry about their reproductive health and they expect their gastroenterologist to initiate this

Jury still out on value of screening for atrial fibrillation

By Reuters Staff NEW YORK (Reuters Health) - There remains insufficient evidence to gauge the benefits and harms of screening for atrial fibrillation in asymptomatic adults aged 50 and older, the U.S.

Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1

By Reuters Staff BERLIN (Reuters) - Germany expects to receive 3.8 million doses of Novavax's newly approved COVID-19 vaccine Nuvaxovid by March 20, the health ministry said on Tuesday, as the

Number of minorities in U.S. internal medicine residencies remains low

By Linda Carroll NEW YORK (Reuters Health) - Little has changed when it comes to minority representation among U.S. internal-medicine residencies, researchers report. An analysis of data on internal

Whether treated with CABG or PCI, heavily calcified lesions tied to higher mortality

By Scott Baltic NEW YORK (Reuters Health) - The presence of at least one heavily calcified lesion (HCL) in patients treated for three-vessel and/or left-main-coronary-artery disease is an independent

Allopurinol treatment for gout appears safe in kidney patients

By Megan Brooks NEW YORK (Reuters Health) - For patients with gout and chronic kidney disease (CKD), treatment with allopurinol to achieve a target serum urate (SU) level does not increase the risk of

Cannabis compound CBD stops coronavirus in test tube, but can it treat COVID?

By Nancy Lapid (Reuters) - Early research suggesting that a popular non-psychoactive compound derived from marijuana might help prevent or treat COVID-19 warrants further investigation in rigorous

Thailand gives green light to growing cannabis at home

By Reuters Staff BANGKOK (Reuters) - Thailand's narcotics board on Tuesday said it would remove cannabis from its drugs list, paving the way for households to grow the plant. Thailand became the first

New York judge strikes down state mask mandate

By Reuters Staff (Reuters) - A New York judge struck down the state's mask mandate on Monday, ruling that it was unconstitutional and a violation of state law, according to the court decision. Judge

Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine

By Michael Erman and Ludwig Burger NEW YORK (Reuters) - Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target

Spain breaks up COVID passport forgery ring

By Reuters Staff MADRID (Reuters) - Spanish police said on Tuesday they had detained seven suspected members of an international criminal gang that created and sold forged COVID-19 passports and

Mandatory COVID shots could deepen German nurse shortage, say care companies

By Nicole Moritz and Zuzanna Szymanska BERLIN (Reuters) - As Germany gears up to make COVID-19 vaccination compulsory in the healthcare sector, the industry fears that resistance among some workers

UPDATE 1-U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments

(Changes source, adds details on FDA decision, Regeneron statement) By Reuters Staff (Reuters) - The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody

Yes signaling pathway implicated in liver cancer development

By Marilynn Larkin NEW YORK (Reuters Health) - Yes, a tyrosine kinase, drove the spread and aggressiveness of hepatocellular cancer (HCC) in cells, mouse models, and an analysis of patient data. "The

Global cancer burden growing, with sociodemographic disparities

By Lisa Rapaport (Reuters Health) - The number of new cancer cases diagnosed globally in 2019 reached an estimated 23.6 million, a 26.3% increase since 2010, according to a recent analysis of the

AI can identify, grade prostate cancer like a pathologist

By Marilynn Larkin NEW YORK (Reuters Health) - Artificial intelligence (AI) algorithms for prostate cancer diagnoses and grading performed as well as pathologists in independent, cross-continental

COVID-19 vaccines seem safe, generally well tolerated in rheumatic, musculoskeletal diseases

By Marilynn Larkin NEW YORK (Reuters Health) - SARS-CoV-2 vaccination seems safe in rheumatic and musculoskeletal disease patients, and likely to trigger flares in less than 5% of cases, a registry

U.S. FDA to restrict use of Regeneron, Lilly COVID antibody drugs - WaPo

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration (FDA) is likely to restrict the use of COVID-19 antibody treatments from Regeneron and Eli Lilly as they are ineffective against the

Curbing poverty has benefits on infant brain development

By Reuters Staff NEW YORK (Reuters Health) - Reducing poverty may have a positive impact on brain development in early childhood, according to data from the Baby's First Years (BFY) study, the first

Israeli health minister says 4th COVID vaccine unlikely for most people

By Reuters Staff JERUSALEM (Reuters) - Israel's health minister said on Monday he did not think Israel will offer a fourth COVID-19 vaccine dose to most people after the government made it available

COVID drives record annual decline in Canadians' life expectancy -Statscan

By Ismail Shakil (Reuters) - COVID-19 contributed to the biggest annual reduction in life expectancy on record in Canada in 2020, the first year of the pandemic, Statistics Canada said in preliminary

Advocacy group urges Pfizer to sell more COVID pills to developing countries

By Michael Erman NEW YORK (Reuters) - An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new COVID-19 pill Paxlovid to developing countries this year, concerned that

Risk of MS relapse high when natalizumab is stopped for pregnancy

By Reuters Staff NEW YORK (Reuters Health) - For women with multiple sclerosis (MS) on natalizumab, there is a high risk of relapse and related disability when the drug is stopped for pregnancy,

Difference between 'retinal age' and actual age may predict premature death

By Linda Carroll NEW YORK (Reuters Health) - The difference between the biological age of a person's retina and their actual age - the retinal age gap - may help estimate lifespan, a new study

Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study

By Reuters Staff (Reuters) - A third booster dose of a COVID-19 vaccine made by either AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have

FEATURE-Canadian hospitals strain as Omicron hits health workers

By Anna Mehler Paperny and Allison Lampert TORONTO/MONTREAL (Reuters) - After a year as an emergency department nurse at a busy Toronto hospital in the middle of the coronavirus pandemic, Aimee

Japan set to widen COVID-19 curbs over most of the country amid Omicron surge

By Reuters Staff TOKYO (Reuters) - Japan on Monday prepared to double the number of regions enacting shortened operating hours for restaurants and other infection curbs to contain a record surge in

Pfizer CEO sees annual COVID vaccine rather than frequent boosters

By Reuters Staff JERUSALEM (Reuters) - Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the

Fourth COVID vaccine shot raises resistance to serious illness for over-60s: Israel

By Reuters Staff JERUSALEM (Reuters) - A fourth dose of COVID-19 vaccine given to people over 60 in Israel made them three times more resistant to serious illness than thrice-vaccinated people in the

UK to begin testing Merck's COVID pill for hospitalised patients

By Reuters Staff (Reuters) - British scientists will begin testing Merck and Ridgeback Biotherapeutics' antiviral pill molnupiravir as a possible treatment for patients hospitalised with COVID-19,

Rich countries' access to foreign nurses during Omicron raises ethical concerns -group

By Emma Farge GENEVA (Reuters) - The Omicron-fuelled wave of COVID-19 infections has led wealthy countries to intensify their recruitment of nurses from poorer parts of the world, worsening dire

Do not assume COVID pandemic reaching 'end game', warns WHO

By Emma Farge and Mrinalika Roy GENEVA (Reuters) - The head of the World Health Organization (WHO) warned on Monday that it was dangerous to assume the Omicron variant would herald the end of COVID-19

Depression screening aids behavioral care referrals for breast cancer patients

By Lisa Rapaport (Reuters Health) - Breast cancer patients who receive depression screening as part of medical oncology checkups are more likely to receive behavioral health referrals than those who

Telemedicine can be effective tool to diagnose sudden sensorineural hearing loss

By Lisa Rapaport (Reuters Health) - Patients who need urgent treatment for sudden sensorineural hearing loss may be effectively identified using telemedicine, a small study suggests. Researchers

Allogenic HCT using younger, unrelated donors may help curb relapse in myelodysplastic syndrome

By Marilynn Larkin NEW YORK (Reuters Health) - For patients with myelodysplastic syndrome (MDS), using younger human leukocyte antigen-matched unrelated donors (MUDs) for allogenic hematopoietic cell

U.S. studies highlight the need for COVID boosters to fight Omicron

By Julie Steenhuysen CHICAGO (Reuters) - Three U.S. studies show that a third dose of an mRNA vaccine is key to fighting the Omicron coronavirus variant, providing 90% protection against

EXCLUSIVE-U.S. opposes plans to strengthen World Health Organization

By Francesco Guarascio, Trevor Hunnicutt and Stephanie Nebehay BRUSSELS (Reuters) - The United States, the World Health Organization's top donor, is resisting proposals to make the agency more

As Japan infections surge, so does risk of pandemic fatigue

By Rocky Swift TOKYO (Reuters) - Japan on Friday acted to contain a record surge in COVID-19 cases with a return to curbs that have however shown diminishing results, while a laggard vaccine booster

U.S. judge blocks Biden federal employee COVID-19 vaccine mandate

By Reuters Staff (Reuters) - A federal judge in Texas ruled on Friday that President Joe Biden could not require federal employees to be vaccinated against COVID-19 and blocked the government from

Anti-abortion activists march in Washington, buoyed by waning U.S. abortion access

By Gabriella Borter WASHINGTON (Reuters) - Anti-abortion advocates gathered in Washington on Friday for the annual "March for Life," their mood boosted by recent state abortion restrictions and the

UPDATE 1-UK designates Omicron sub-lineage a variant under investigation

(Adds further details from UKHSA) By Reuters Staff LONDON/COPENHAGEN (Reuters) - The UK Health Security Agency on Friday designated a sub-lineage of the dominant and highly transmissible Omicron

UPDATE 1-Is COVID retreating in the U.S.? Data paints encouraging scenario

(Updates with latest data) By Maria Caspani NEW YORK (Reuters) - New coronavirus cases are falling in parts of the United States hit hardest by the fast-spreading Omicron variant, according to a

People who've had COVID-19 may still benefit from vaccination after several months

By Megan Brooks NEW YORK (Reuters Health) - Prior to the emergence of Omicron, both people previously infected with the novel coronavirus and those vaccinated against it were at much lower risk of

Much cheaper synthetic mesh outperforms biological mesh for ventral hernia repair

By Reuters Staff NEW YORK (Reuters Health) - At a fraction of the cost, synthetic mesh appears to be as safe as biological mesh for ventral hernia repair and leads to significantly fewer recurrences,

For many broken wrists, molded casts work just as well as pins

By Linda Carroll NEW YORK (Reuters Health) - Surgical fixation with pins is no better than the traditional plaster cast for a dorsally displaced distal radius fracture that needs manipulation, a new

Protective gene variant against COVID-19 identified

By Reuters Staff NEW YORK (Reuters Health) - Researchers have identified a human genetic variant that appears to protect against severe COVID-19 infection, and which could serve as a target for drug

Cannabis may increase risk of fatal complication after aneurysmal subarachnoid hemorrhage

By Scott Baltic NEW YORK (Reuters Health) - Recent use of cannabis significantly increases patients' risk of a potentially fatal complication called delayed cerebral ischemia (DCI) following a rare

Anti-vax stance is a showstopper for Comédie Française stage manager

By Layli Foroudi PARIS (Reuters) - The Comédie Française re-opened its doors months ago after COVID-19 curbs were lifted, but stage manager Florence Passy has yet to see her troupe of actors perform

Italy to set aside 150 mln euros for COVID vaccination compensation - draft

By Reuters Staff ROME (Reuters) - Italy plans to set aside 150 million euros ($169.91 million) to compensate those suffering side effects from COVID-19 vaccinations, a draft decree seen by Reuters

WHO recommends reduced dose Pfizer COVID vaccine for under 12s

By Mrinalika Roy and Manojna Maddipatla (Reuters) - The World Health Organization on Friday recommended extending the use of a reduced dosage of Pfizer's COVID-19 vaccine to children aged 5 to 11

CORRECTED-Alzheimer's patient groups protest U.S. Medicare coverage proposal limiting use of new drugs

(Corrects paragraph 13. Chris Meekins is a healthcare policy analyst at Raymond James, not Leerink.) By Deena Beasley (Reuters) - Alzheimer's patient groups, disappointed by Medicare's plan to sharply

UK designates Omicron sub-lineage a variant under investigation

By Reuters Staff LONDON/COPENHAGEN (Reuters) - The UK Health Security Agency on Friday said it had designated a sub-lineage of the dominant and highly transmissible Omicron coronavirus variant as a

EU told to prime for fourth COVID vaccine dose, if needed

By Francesco Guarascio BRUSSELS (Reuters) - European Union health ministers were told on Friday to prepare to deploy a fourth dose of COVID-19 vaccines as soon as data showed it was needed, as the

Is COVID retreating in the U.S.? Data paints encouraging scenario

By Maria Caspani NEW YORK (Reuters) - New coronavirus cases are falling in parts of the United States hardest hit by the fast-spreading Omicron variant, according to a Reuters analysis of public

Alzheimer's patient groups protest U.S. Medicare coverage proposal limiting use of new drugs

By Deena Beasley (Reuters) - Alzheimer's patient groups, disappointed by Medicare's plan to sharply limit coverage of new drugs for the brain-wasting disease, are planning publicity and lobbying

REFILE-Prosthetic-joint infections not related to invasive dental procedures

(Fixes formatting in Jan 20 story, with no changes to text.) By Linda Carroll NEW YORK (Reuters Health) - Patients with prosthetic joints do not need antibiotics prior to an invasive dental procedure

REFILE-Nivolumab with chemo may be new first-line option for stomach cancer

(Fixes formatting in Jan 20 story, with no changes to text.) By Reuters Staff NEW YORK (Reuters Health) - Adding nivolumab to oxaliplatin-based chemotherapy significantly improves progression-free

REFILE-AI-powered, ECG-enabled stethoscope detects heart failure in primary care

(Fixes formatting of Jan 20 story, with no changes to text.) By Reuters Staff NEW YORK (Reuters Health) - An artificial intelligence (AI)-powered "smart" stethoscope that records electrocardiograms (

REFILE-Higher corticosteroid dose tied to HBV reactivation in people with resolved infection

(Refiles Jan 20 story to fix formatting, with no changes to text.) By Reuters Staff NEW YORK (Reuters Health) - In people with resolved hepatitis B virus (HBV) infection, exposure to higher doses of

REFILE-People with HIV at higher risk of heart failure

(Fixes formatting in Jan 20 story, with no changes to text.) By Reuters Staff NEW YORK (Reuters Health) - People infected with HIV are at increased risk of heart failure, with women, younger people

Skin toxicity may predict immune checkpoint inhibitor response

By Marilynn Larkin NEW YORK (Reuters Health) - In cancer patients, cutaneous immune-related adverse events (cirAEs) were strongly associated with response to immune checkpoint inhibitors (ICIs) and

Africa calls for donated vaccines with shelf life of 3 to 6 months

By Alexander Winning JOHANNESBURG (Reuters) - Africa's top public health bodies on Thursday called for donated COVID-19 vaccines to come with a shelf life of three to six months so countries could

France to loosen COVID curbs in February, allowing popcorn in cinemas again

By Sudip Kar-Gupta and Marc Angrand PARIS (Reuters) - France will ease work-from-home rules from early February and allow nightclubs to reopen two weeks later as the general COVID-19 situation in the

Simple screening tools could help identify COPD in low-, middle-income countries

By Marilynn Larkin NEW YORK (Reuters Health) - Three screening tools for chronic obstructive pulmonary disease (COPD), based on questionnaires and peak expiratory flow (PEF), were feasible to

Sputnik V maintains higher Omicron-antibody levels than Pfizer in preliminary study

By Reuters Staff MOSCOW (Reuters) - A small preliminary laboratory study has shown that levels of Omicron-neutralizing antibodies of people vaccinated with Russia's Sputnik V vaccine did not decline

Israel to scrap quarantine for children exposed to COVID carriers

By Reuters Staff JERUSALEM (Reuters) - Israel will ditch mandatory quarantine for children exposed to COVID-19 carriers, the government said on Thursday, citing a need to relieve parents and schools

Alphabet's Verily signs L'Oreal in multi-year skin deal as losses grow

By Paresh Dave (Reuters) - Alphabet Inc's health tech arm Verily on Thursday announced its newest tie-up in its search for sustainable revenue, saying it would study skin health and explore new

Prosthetic-joint infections not related to invasive dental procedures

By Linda Carroll NEW YORK (Reuters Health) - Patients with prosthetic joints do not need antibiotics prior to an invasive dental procedure to prevent infections, a new study from the UK suggests.

Nivolumab with chemo may be new first-line option for stomach cancer

By Reuters Staff NEW YORK (Reuters Health) - Adding nivolumab to oxaliplatin-based chemotherapy significantly improves progression-free survival (PFS) in patients with untreated, HER2-negative,

AI-powered, ECG-enabled stethoscope detects heart failure in primary care

By Reuters Staff NEW YORK (Reuters Health) - An artificial intelligence (AI)-powered "smart" stethoscope that records electrocardiograms (ECGs) can screen for heart failure with reduced ejection

People with HIV at higher risk of heart failure

By Reuters Staff NEW YORK (Reuters Health) - People infected with HIV are at increased risk of heart failure, with women, younger people and Asian or Pacific Islanders at highest risk, according to a

Higher corticosteroid dose tied to HBV reactivation in people with resolved infection

By Reuters Staff NEW YORK (Reuters Health) - In people with resolved hepatitis B virus (HBV) infection, exposure to higher doses of corticosteroids is associated with an increased risk of HBV

ANALYSIS-How Omicron highlights fading hope of herd immunity from COVID

By Julie Steenhuysen CHICAGO (Reuters) - The Omicron variant, which is spreading far faster than previous versions of the coronavirus, is not likely to help countries achieve so-called herd immunity

U.S. will keep probing diplomats' health incidents -Blinken

By Reuters Staff BERLIN (Reuters) - The United States government will continue to investigate the possible cause of anomalous health incidents that have affected American diplomats around the world

S.Africans intrigued by Desmond Tutu's choice of aquamation

By Reuters Staff CAPE TOWN (Reuters) - Anti-apartheid hero Desmond Tutu's choice of aquamation over cremation or traditional burial came as a surprise to some South Africans, while others were

Lebanon's healthcare on brink of collapse amid crisis, says minister

By Timour Azhari, Laila Bassam and Maya Saad BEIRUT (Reuters) - Lebanon's healthcare system is crumbling amid an economic crisis that has led to an exodus of thousands of doctors and nurses, forced

Cheap version of Merck COVID pill to be made for poorer nations

By Reuters Staff BRUSSELS (Reuters) - A U.N.-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck & Co's COVID-19 pill molnupiravir for poorer nations,

Omicron has not increased hospitalisation of elderly, UK COVID advisers say

By Reuters Staff LONDON (Reuters) - A wave of Omicron coronavirus cases has not led to an increase in the hospitalisation of the elderly that was expected despite there being more cases in that age

Spore therapy cuts C. difficile reinfection by 68% in 8-week study

By Gene Emery (Reuters Health) - An experimental three-day therapy that adds Firmicutes spores to the gut can reduce the risk of Clostridioides difficile reinfection by 68% according to the results

Down syndrome tied to accelerated immune system aging, higher risk of autoimmune disorders

By Marilynn Larkin NEW YORK (Reuters Health) - Individuals with Down syndrome (DS) show accelerated aging of their immune systems, putting them at higher risk of autoimmune disorders, researchers say.

Undiagnosed Fragile X syndrome common in general population

By Lisa Rapaport (Reuters Health) - Fragile X syndrome may be underdiagnosed, particularly among women, a U.S. study suggests. Researchers examined electronic health record data for 1.7 million

App linking glucose monitor to pump improves diabetes control in young children

By Gene Emery NEW YORK (Reuters Health) - University of Cambridge researchers behind a system for linking an insulin pump and a glucose monitor say it provides significantly better control for young

No need to repeat celiac screening for five years after negative serology

By Marilynn Larkin NEW YORK (Reuters Health) - If children test negative for celiac disease on antibody screening, the risk of receiving a clinical diagnosis within five years is "very low,"

EXCLUSIVE-Google aims to improve spotty enforcement of children's ads policy

By Paresh Dave (Reuters) - Alphabet Inc's Google said this week it would immediately improve enforcement of an age-sensitive ad policy after Reuters found ads for sex toys, liquor and high-risk

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.